Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 32 of 47
  1. REGN3500

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. REGN3918

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. REGN4461

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. REGN475 (SAR164877)

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial
  5. REGN5069

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  6. REGN5381

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  7. REGN5713-5714-5715

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. REGN6490

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule terminated

    2 trials
  9. REGN668

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial
  10. REGN668: Injection Rate 1

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  11. REGN727

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  12. REGN727

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. REGN728

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial
  14. REGN7508 (IV)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  15. REGN7544

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. REGN7999

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  17. REGN846

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial
  18. REGN9035

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. REGN9533

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  20. REGN9933

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. RHO-11-003

    Lacuna Pharma Pty Ltd

    not applicable (submitted trial is a pharmacokinetic and pharmacodynamic safety study in healthy subjects)

    phase 1 other active

    1 trial
  22. RT-102 (80 μg)

    Rani Therapeutics Holdings

    Healthy Volunteers

    phase 1 other completed

    1 trial
  23. Radiolabeled Prucalopride Succinate

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  24. Radiolabeled SPD557

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.